CAR T-cell therapy for leukaemia leads to remissions in clinical trial
Researchers at Fred Hutchinson Cancer Research Center showed about 70 percent of patients with the most common…
Researchers at Fred Hutchinson Cancer Research Center showed about 70 percent of patients with the most common…
Although most patients with relapsed B-cell acute lymphoblastic leukaemia (B-ALL) experienced complete response after treatment…